These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Understanding the somatic-type malignant differentiation in male germ-cell cancer: a work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 2008;26:595-9. Necchi A; Nicolai N; Colecchia M; Salvioni R Urol Oncol; 2009; 27(2):218; author reply 218-9. PubMed ID: 19285238 [No Abstract] [Full Text] [Related]
58. Physical activity in long-term survivors of germ-cell cancer. Sleijfer S; de Wit R Eur J Cancer; 2003 Jun; 39(9):1191-3. PubMed ID: 12763205 [No Abstract] [Full Text] [Related]
59. Growth and chemotherapy of a human germ-cell tumour line (GCT 27). Schlappack OK; Bush C; Delic JI; Steel GG Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535 [No Abstract] [Full Text] [Related]
60. Re: First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Richie JP J Urol; 2015 Mar; 193(3):850. PubMed ID: 25765390 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]